Optimal Treatment of Carotid Artery Disease

Elad I. Levy*, J. Mocco, Rodney M. Samuelson, Robert D. Ecker, Babak S. Jahromi, L. Nelson Hopkins

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

42 Scopus citations


Extracranial carotid artery disease accounts for approximately 25% of ischemic strokes. Although carotid endarterectomy (CEA) is the established gold standard for carotid revascularization, carotid artery angioplasty and stenting (CAS) is continually developing into a safer and more efficacious method of stroke prevention. Embolic protection, improving stent designs, and ever-increasing surgeon experience are propelling CAS towards equipoise with and possible superiority to CEA. One multicenter randomized trial and several nonrandomized registries have successfully established CAS as an accepted treatment for high-risk patients. Clinicians must strive to perform well-designed clinical trials that will continue to aid understanding and improve application of both endovascular and open techniques for extracranial carotid revascularization. We review the data published to date regarding the indications for and recent developments in the use of CAS.

Original languageEnglish (US)
Pages (from-to)979-985
Number of pages7
JournalJournal of the American College of Cardiology
Issue number10
StatePublished - Mar 11 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Optimal Treatment of Carotid Artery Disease'. Together they form a unique fingerprint.

Cite this